Tubuloglomerular feedback is decreased in COX-1 knockout mice after chronic angiotensin II infusion

Magali Araujo1, William J Welch

  • 1Division of Nephrology and Hypertension, Department of Medicine, Georgetown University, 4000 Reservoir Road, Washington, DC 20057, USA.

Insights

Cyclooxygenase-1 (COX-1) prostaglandins partially mediate angiotensin II (ANG II) increases in tubuloglomerular feedback (TGF). COX-2 prostaglandins, however, offset this effect, impacting renal hemodynamics in COX-1 knockout mice.

Area of Science:

  • Nephrology
  • Renal Physiology
  • Prostaglandin Biology

Background:

  • Prostaglandins (PGs), synthesized by cyclooxygenase (COX) enzymes, are key regulators of renal hemodynamics.
  • COX-1 and COX-2 isoforms exhibit distinct kidney expression patterns.
  • Angiotensin II (ANG II) acutely stimulates COX-2-dependent PG production in the renal cortex.

Purpose of the Study:

  • To investigate the role of COX-1-derived PGs in modulating tubuloglomerular feedback (TGF) during chronic ANG II infusion.
  • To determine the impact of COX-1 genetic deletion on TGF regulation by ANG II.
  • To elucidate the interplay between COX-1 and COX-2 in mediating ANG II effects on renal function.

Main Methods:

  • Utilized COX-1 knockout (KO) and wild-type (WT) mice subjected to chronic ANG II infusion.
  • Measured TGF responses under basal and stimulated conditions.
  • Administered a selective COX-2 inhibitor (SC-58,236) to COX-1 KO mice.
  • Quantified urinary excretion of prostaglandin metabolites (6-keto-PGF(2alpha) and TxB(2)).
  • Monitored mean arterial pressure (MAP).

Main Results:

  • Basal TGF was comparable between COX-1 KO and WT mice.
  • Chronic ANG II infusion augmented TGF in WT mice but significantly reduced it in COX-1 KO mice.
  • COX-2 inhibition in COX-1 KO mice prevented the ANG II-induced TGF reduction.
  • ANG II increased urinary PGI(2) metabolite excretion, with no change in TxA(2) metabolite excretion.
  • MAP increased similarly in WT and COX-1 KO mice after ANG II, but not in COX-1 KO mice pretreated with the COX-2 inhibitor.

Conclusions:

  • COX-1-generated PGs play a significant role in mediating ANG II-induced increases in TGF.
  • COX-2-derived PGs counteract the effects of COX-1 PGs, offsetting the ANG II-mediated augmentation of TGF.
  • The balance between COX-1 and COX-2 activity is critical for regulating TGF responses to ANG II in the kidney.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...